Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Razenberg, L. G. E. M.
van Gestel, Y. R. B. M.
de Hingh, I. H. J. T.
Loosveld, O. J. L.
Beerepoot, L. V.
Creemers, G. J.
Lemmens, V. E. P. P.
Funding for this research was provided by:
Netherlands Organisation for Health Research and Development (NL) (project numbers 152002012 and 152001022)